In Brief: InterVentional Technologies
This article was originally published in The Gray Sheet
InterVentional Technologies: Premarket approval application for the company's Barath cutting balloon will be reviewed March 4 at a meeting of FDA's Circulatory System Devices Advisory Panel, IVT announces Feb. 8 at the Piper Jaffray Medical Device Conference in New York City. Used in percutaneous transluminal coronary angioplasty, the cutting balloon incorporates microsurgical blades with an angioplasty balloon to incise a coronary lesion ahead of balloon expansion. The PMA will be one of two reviewed by the panel, which will meet at the Hilton Hotel in Gaithersburg, Maryland...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.